News & Events

How do Alzheimer’s biomarkers change over time?

Biomarkers for the diagnosis of Alzheimer’s disease The characteristic symptoms of Alzheimer’s disease, such as progressive memory loss or other cognitive deficits and behavioral disorders, can make us suspect the diagnosis of this disease. This suspicion...

Super-resolution is here for amyloid plaques

Non-fibrillar amyloid-β (Aβ) plaques are considered to be a critical component of Alzheimer’s disease. Characterization of these species comes mainly from studies in cellular or animal models, but there is little data in intact human samples due to the lack of...

Is obesity a risk factor for Alzheimer’s disease?

Obesity and Alzheimer It has been established that middle-age obesity is a risk factor for Alzheimer’s disease, but the results from studies in older people are contradictory. Our recent study would explain the discrepancies on this topic. This work is the...

María Carmona-Iragui receives the Doctoral Extraordinary Award

Dr. María Carmona-Iragui has recently received the Doctoral Thesis Extraordinary Award in Neuroscience for her work entitled: “Sporadic cerebral amyloid angiopathy: beyond lobar intracerebral hemorrhage. Multimodal biomarker studies of atypical presentations”. Her...